Health Buzz: More Vytorin Studies and Other Health News
Posted September 3, 2008
Reader Comments
Vytorin & Cancer Risk
The problem with new drugs like Vytorin is that we must rely on short-term studies & short-term observation in order to gamble on the drug's safety. There is, presently, only one cholesterol medication that has not only proven to be most effective in decreasing mortality, but has been tested and used safely for more than 60 tears. The therapeutic use of niacin ( see cholesterolscore.com )has been studied in 6 major clinical trials with cardiovascular endpoints. Niacin can not be protected by a patent, so BigPharma hasn't, until recently, shown much interest in promoting it.
